Gilenya: new MS drug approved by Health CanadaHealth Canada approves first disease-modifying oral treatment for multiple sclerosis in Canada. Long-term PPI use may cause serious hypomagnesemiaU.S. FDA communicating safety concerns regarding potential development of hypomagnesemia when PPIs taken for prolonged periods. Cardiology | Drink to your health LETTER: Online ‘data clouds’ offer a brighter future for EMRs? New drug fights C. diff with fewer recurrences Question remains about whether treatment period should be extended Pharmacists not happy with Nunavut's remote dispensing "plan" Territory looks at bypassing community pharmacy with tele-pharmacist counselling and technicians managing drug distribution. Obesity | Patients really do heed your weight-loss advice Osteoporosis | Canadian study confirms link between bisphosphonates and fracture risk Peak experience: Climbing a fundraising mountain Rinse and spit away preterm birth risk Mouthwash is good for more than just gums, study shows Rx subs often OK if no kickback When patient privacy was lip service A lot of what used to go on in psychiatry’s inpatient wards was there for all to see and hear First Previous 1688 1689 1690 1691 1692 Next Last
